
Sign up to save your podcasts
Or


Cancer is a disease that will affect 1 in 5 people in our lifetime, and it’s estimated that around 20 million people worldwide will be diagnosed with some form of cancer in 2025.
But how might a vaccine help in the treatment of cancer?
Numerous trials began testing the viability of cancer vaccines in 2024, including one for melanoma and another for lung cancer.
With all the promise that these new cancer vaccine trials bring for cancer patients, we explore the different ways in which vaccines could work within the body, and how the time at which future vaccines are administered may vary according to the cancers they are targeting.
This week on the Inquiry we’re asking: Are we close to a cancer vaccine?
Presenter: Tanya Beckett
Contributors:
Meredith McKean, director of Melanoma and Skin Cancer Research for Sarah Cannon Research Institute at Tennessee Oncology
Samra Turajlic, Chief Investigator of translational studies into melanoma and kidney cancer at the Francis Crick Institute and Professor at the Institute of Cancer Research
Eduardo Vilar-Sanchez, professor in the department of Clinical Cancer Prevention at The University of Texas MD Anderson Cancer Center
Patrick Ott, Clinical Director at Melanoma Disease Center at the Dana-Farber Institute
By BBC World Service4.6
695695 ratings
Cancer is a disease that will affect 1 in 5 people in our lifetime, and it’s estimated that around 20 million people worldwide will be diagnosed with some form of cancer in 2025.
But how might a vaccine help in the treatment of cancer?
Numerous trials began testing the viability of cancer vaccines in 2024, including one for melanoma and another for lung cancer.
With all the promise that these new cancer vaccine trials bring for cancer patients, we explore the different ways in which vaccines could work within the body, and how the time at which future vaccines are administered may vary according to the cancers they are targeting.
This week on the Inquiry we’re asking: Are we close to a cancer vaccine?
Presenter: Tanya Beckett
Contributors:
Meredith McKean, director of Melanoma and Skin Cancer Research for Sarah Cannon Research Institute at Tennessee Oncology
Samra Turajlic, Chief Investigator of translational studies into melanoma and kidney cancer at the Francis Crick Institute and Professor at the Institute of Cancer Research
Eduardo Vilar-Sanchez, professor in the department of Clinical Cancer Prevention at The University of Texas MD Anderson Cancer Center
Patrick Ott, Clinical Director at Melanoma Disease Center at the Dana-Farber Institute

7,834 Listeners

376 Listeners

527 Listeners

891 Listeners

1,074 Listeners

307 Listeners

5,494 Listeners

1,820 Listeners

970 Listeners

588 Listeners

2,115 Listeners

363 Listeners

974 Listeners

405 Listeners

423 Listeners

233 Listeners

850 Listeners

334 Listeners

364 Listeners

68 Listeners

482 Listeners

366 Listeners

233 Listeners

997 Listeners

331 Listeners

3,211 Listeners

66 Listeners

826 Listeners

560 Listeners

624 Listeners

368 Listeners

263 Listeners

57 Listeners

77 Listeners

18 Listeners